JAGX: Jaguar Health Inc

JAGX新闻

• 21:05 Jaguar Health at Emerging Growth Conference 85: Strategic Drug Development Insights
• 13:08 Jaguar Health to meet with FDA on crofelemer for rare pediatric disease
• 13:52 Jaguar Health extends Lucid Capital Markets role in ATM agreement to year-end
• 20:01 Clean Inc. and Sono Group NV at Emerging Growth Conference: Strategic Innovations
• 13:32 Proof-of-Concept Results Show Jaguar Health’s Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
• 13:13 Jaguar Health considers cryptocurrency for treasury reserves
• 13:06 Jaguar Health Board authorizes crypto treasury reserve
• 13:04 Jaguar Health seeks EU approval for dog diarrhea treatment
• 20:21 Jaguar Health extends maturity date for $2.57 million in notes
• 13:48 Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts
• 14:14 First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
• 20:28 REMINDER: Jaguar Health to Conduct Fireside Chat 9AM ET June 10 as Part of Lytham Partners’ Spring 2025 Spotlight Series
• 13:05 Jaguar Health Eyes FDA Orphan Drug Designation for Crofelemer
• 13:16 Jaguar Health to Conduct Fireside Chat June 10 Regarding Company’s Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners’ Spring 2025 Spotlight Series
• 12:14 Jaguar Health announces $1.5 million direct offering
• 13:28 First Patient Randomized in Jaguar Health’s Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID)
• 18:40 Jaguar Health Reports First Quarter 2025 Financials
• 13:16 Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates
• 06:43 Upcoming Stock Splits This Week (March 24 to March 28) – Stay Invested - TipRanks.com
• 16:01 Why Jaguar Health (JAGX) Stock Is Trading Lower - Jaguar Health (NASDAQ:JAGX)